13F holdings exceed the share count. This is normal for heavily shorted stocks: shares lent to short sellers are reported by the lender and again by whoever bought them. Related filers occasionally report the same position twice as well.

Share classes (cover page of the 10-Q filed 2026-08-13, as of 2026-08-12)

Class	Listed	Shares outstanding	Held by 13F filers	% of class	Holders	CUSIP
Common stock	XAIR · NASDAQ	957,631	1,375,951	143.7%	28	08862L202

Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.

Securities (CUSIPs held in 13F this quarter)

tick to combine

Count	CUSIP	Class (as filers write it)	Holders	Shares held	Class shares	% of class	Value	Options	Mapped via
	08862L202	COM NEW	28	1,375,951	957,631	143.7%	$607K	—	13DG	holders →
	08862L301	COMnot common	1	15	—	—	$7	—	13DG	holders →

Totals combine the ticked CUSIPs and update as you tick: common-stock classes by default; preferreds, notes, warrants and depositary shares are listed but not counted. "holders →" shows a single CUSIP on its own. Bonds are held as a principal amount, not shares. Options positions are never counted as holdings. 1 further CUSIPs map to this company (mostly bonds) but no 13F filer held them this quarter.

Top holders (1 of 1 · 08862L301)

change vs 2026-03-31

#	Filer	Shares / principal	% of class	Value	Change
1	SBI Securities Co., Ltd.	15	—	$7	NEW

Large holders from 13D/13G (latest per reporting person, last 2 years)

Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.

Reporting person	Form	Filed	Event	Shares	% of class
Lin Yi-Chien	SCHEDULE 13G/A	2026-10-02	2026-09-28	145,393	14.8%
Dmitry Balyasny	SCHEDULE 13G/A	2026-08-14	2026-06-30	763,266	5.3%
Dames GP LLC	SCHEDULE 13G/A	2026-08-14	2026-06-30	763,266	5.3%
Balyasny Asset Management Holdings LP	SCHEDULE 13G/A	2026-08-14	2026-06-30	763,266	5.3%
BALYASNY ASSET MANAGEMENT L.P.	SCHEDULE 13G/A	2026-08-14	2026-06-30	763,266	5.3%
BAM GP LLC	SCHEDULE 13G/A	2026-08-14	2026-06-30	763,266	5.3%
Anand Parekh	SCHEDULE 13G/A	2026-05-15	2026-03-31	0	0%
Alyeska Fund GP, LLC	SCHEDULE 13G/A	2026-05-15	2026-03-31	0	0%
Alyeska Investment Group, L.P.	SCHEDULE 13G/A	2026-05-15	2026-03-31	0	0%
Avenue Venture Opportunities Partners II, LLC	SCHEDULE 13G/A	2025-02-04	2024-12-31	4,823,723	5.31%
Avenue Venture Opportunities Fund, L.P.	SCHEDULE 13G/A	2025-02-04	2024-12-31	3,229,149	3.54%
Avenue Venture Opportunities Fund II, L.P.	SCHEDULE 13G/A	2025-02-04	2024-12-31	4,823,723	5.31%
Avenue Capital Management II, L.P.	SCHEDULE 13G/A	2025-02-04	2024-12-31	8,072,872	8.86%
Avenue Venture Opportunities Partners, LLC	SCHEDULE 13G/A	2025-02-04	2024-12-31	3,229,149	3.54%
GL Venture Opportunities Partners II, LLC	SCHEDULE 13G/A	2025-02-04	2024-12-31	4,823,723	5.31%
GL Venture Opportunities Partners, LLC	SCHEDULE 13G/A	2025-02-04	2024-12-31	3,229,149	3.54%
Marc Lasry	SCHEDULE 13G/A	2025-02-04	2024-12-31	8,072,872	8.86%

Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.